SUBSCRIBE
SUBSCRIBE

Nevada

PRESS RELEASES
Press Releases
Precision Biologics Manufacturing Launches Advanced Biologics Facility
October 1, 2025
 · 
3 min read
Press Releases
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
September 29, 2025
 · 
3 min read
Press Releases
Corstasis Therapeutics and U.S. Heart and Vascular® Collaboration Will Seek to Improve Heart Failure Care with ENBUMYST™ (Bumetanide Nasal Spray)
September 25, 2025
 · 
5 min read
Press Releases
Avant Technologies, Art-Islets, and Austrianova Announce Joint Venture to Advance Diabetes Treatment
September 25, 2025
 · 
5 min read
Press Releases
Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease
September 16, 2025
 · 
5 min read
Press Releases
Corstasis Therapeutics Strenghtens Leadership Team with the Appointment of Dr. Amin Medjamia as VP of Medical Affairs
September 11, 2025
 · 
2 min read
Press Releases
Kaiser Permanente Launches in Nevada in 2026
September 11, 2025
 · 
4 min read
Press Releases
Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789
September 4, 2025
 · 
2 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.
September 4, 2025
 · 
3 min read
Press Releases
Kerecis Fish-Skin Technology to Make a Splash at SAWC Fall 2025
September 3, 2025
 · 
5 min read
Press Releases
AcariaHealth Sparks Innovation at 2025 Healthcare Advocate Summit with Hackathon and Expert Panels
August 27, 2025
 · 
2 min read
Press Releases
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
August 21, 2025
 · 
2 min read
Press Releases
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference
August 20, 2025
 · 
1 min read
Press Releases
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
August 19, 2025
 · 
3 min read
Press Releases
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
August 15, 2025
 · 
11 min read
Press Releases
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes
August 14, 2025
 · 
8 min read
Press Releases
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
August 13, 2025
 · 
5 min read
Press Releases
BioVie Inc. Announces Closing of $12 Million Public Offering
August 12, 2025
 · 
4 min read
Press Releases
BioVie Inc. Announces Pricing of $12 Million Public Offering
August 8, 2025
 · 
5 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Load More